Effectiveness and Safety of PD-1 Inhibitors’ Treatment for Patients with Non-Small-Cell Lung Cancer in China: A Real-World Study

Table 2

Relationship between patient clinical characteristics and treatment responses.

Variables	OR (95% CI)	value
Ages (<65 years vs. ≥65 years)	1.259 (0.632, 2.505)	0.513
Smoking history (current or ex-smoker vs. never-smoker)	0.492 (0.235, 1.027)	0.059
Sex (male vs. female)	1.815 (0.746, 4.420)	0.189
Histology (nonsquamous vs. squamous)	1.315 (0.653, 2.645)	0.443
Presence of treating with antibiotic during immunotherapy (yes vs. no)	1.526 (0.617, 2.567)	0.526
Pathological staging (III vs. IV)	0.755 (0.345, 1.653)	0.482
Therapy lines (first-line vs. posterior-line)	0.610 (0.306, 1.216)	0.160
Presence of irAEs (yes vs. no)	0.947 (0.337, 2.658)	0.917
Presence of serious AEs (yes vs. no)	0.872 (0.403, 1.888)	0.728